Actinium Pharmaceuticals
ATNM
#10403
Rank
S$57.56 M
Marketcap
S$1.83
Share price
-3.38%
Change (1 day)
1.91%
Change (1 year)

Market capitalization of Actinium Pharmaceuticals (ATNM)

Market cap: S$57.56 Million

As of November 2026 Actinium Pharmaceuticals has a market cap of S$57.56 Million. This makes Actinium Pharmaceuticals the world's 10403th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Actinium Pharmaceuticals from 2011 to 2026

End of year Market Cap

Year Marketcap Change
2026S$57.56 M-5.45%
2025S$60.87 M19.64%
2024S$50.88 M-72.33%
2023S$0.18 B-49.45%
2022S$0.36 B102.22%
2021S$0.17 B-0.55%
2020S$0.18 B274.27%
2019S$48.33 M-20.98%
2018S$61.17 M-13.88%
2017S$71.02 M0.61%
2016S$70.59 M-64.94%
2015S$0.20 B-13.69%
2014S$0.23 B27.24%
2013S$0.18 B367.18%
2012S$39.23 M2369.33%
2011S$1.58 M

End of Day market cap according to different sources

On Nov 2nd, 2026 the market cap of Actinium Pharmaceuticals was reported to be:

S$57.96 Million
by Nasdaq info icon info icon
S$57.56 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Genocea Biosciences
GNCA
S$0 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$5.82 B 10,019.54%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$14.23 B 24,629.91%๐Ÿ‡บ๐Ÿ‡ธ USA